<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 3-MOS <F1> <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> MAR-31-1999 <CASH> 2,932 <SECURITIES> 1,058 <RECEIVABLES> 4,905 <F2> <ALLOWANCES> 0 <INVENTORY> 4,008 <CURRENT-ASSETS> 13,103 <PP&E> 1,531 <F2> <DEPRECIATION> 0 <TOTAL-ASSETS> 16,259 <CURRENT-LIABILITIES> 3,300 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 124 <OTHER-SE> 12,810 <TOTAL-LIABILITY-AND-EQUITY> 12,934 <SALES> 6,196 <TOTAL-REVENUES> 7,770 <CGS> 4,304 <TOTAL-COSTS> 4,542 <OTHER-EXPENSES> 1,655 <F3> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (1,277) <INCOME-TAX> 15 <INCOME-CONTINUING> (1,292) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (1,292) <EPS-PRIMARY> (0.11)<F4> <EPS-DILUTED> (0.11) <FN> <F1> The 13-week period from January 3, 1999 to April 3, 1999 is referred to herein as the three months ended March 31, 1999. Year-to-date data is for quarters presented. <F2> Item shown net of allowance, consistent with the balance sheet presentation. <F3> Item consists of research and development. <F4> Item consists of basic earnings per share. </FN>